- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02889081
Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD) (MKNFOAD)
March 16, 2023 updated by: Weili Yan, Children's Hospital of Fudan University
Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis
The study is a prospective birth cohort study and the purpose is to describe the status of maternal key nutrients(eg.
folate and vitamin D) supplementation among pregnancies at early gestation in Shanghai, to find out the association between the level of serum key nutrients and atopic dermatitis (AD) in offsprings during 6 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study based on Shanghai pregnancy population is a prospective birth cohort.
The investigators obtain the data of participants' folic acid and vitamin D supplement intake through the questionnaire at 12-14 gestational weeks.
And the investigators collect participants' blood samples during gestation to directly detect the biological exposure levels of folate and vitamin D. In the follow-up, skin barrier function is evaluated at time of infant 24-48 hours, 42 days and 6 months.
During 6 months from birth, the incidence of AD is investigated on offsprings.
This cohort study is aimed to (1) clarify the association between prenatal key nutrients with offspring AD; (2) assess the role of maternal key nutrients in the skin barrier of offsprings.
It will be a good evidence for the AD prevention and a meaningful protocol to reduce the incidence of AD by its unique design.Univariate and multivariate association analyses will be performed to identify risk factors to AD by using multivariate logistic regression model.
Study Type
Observational
Enrollment (Actual)
487
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China, 201102
- Children Hospital of Fudan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Pregancies at early gestation and offspring from Minhang Maternal and Children Health Care Hospital in Shanghai from June 2016
Description
Inclusion Criteria:
- Mother plans to proceed prenatal care and delivery in Minhang Maternal and Children Health Care Hospital
- Offspring plans to stay in Shanghai until 6 months and proceed follow-up in Children's Hospital of Fudan University
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
infants from birth cohort with AD
maternal biological folate level and maternal biological vitamin D level and offspring's incidence of suffering from atopic dermatitis
|
supplementation status and serum level
supplementation status and serum level
|
infants from birth cohort without AD
maternal biological folate level and maternal biological vitamin D level and offspring's incidence of not suffering from atopic dermatitis
|
supplementation status and serum level
supplementation status and serum level
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infant atopic dermatitis
Time Frame: incident of AD during 6 months after birth, diagnosis confirmed based on disease history till 12 months
|
Disease diagnosis according to the criteria of Williams
|
incident of AD during 6 months after birth, diagnosis confirmed based on disease history till 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal RBC folate level
Time Frame: 12-14 gestational weeks
|
Whole blood sample collected will be used for evaluation
|
12-14 gestational weeks
|
Maternal serum vitamin D level
Time Frame: 12-14 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
12-14 gestational weeks
|
Maternal serum vitamin D level
Time Frame: 22-26 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
22-26 gestational weeks
|
Maternal serum vitamin D level
Time Frame: 34-36 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
34-36 gestational weeks
|
Maternal serum folate level
Time Frame: 12-14 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
12-14 gestational weeks
|
Maternal serum folate level
Time Frame: 22-26 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
22-26 gestational weeks
|
Maternal serum folate level
Time Frame: 34-36 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
34-36 gestational weeks
|
Maternal folic acid supplement intake
Time Frame: 12-14 gestational weeks
|
Questionnaire survey will be used to obtain the data of maternal supplement intake
|
12-14 gestational weeks
|
Maternal vitamin D supplement intake
Time Frame: 12-14 gestational weeks
|
Questionnaire survey will be used to obtain the data of maternal supplement intake
|
12-14 gestational weeks
|
Infant skin barrier function (Transepidermal Water Loss, TEWL)
Time Frame: infant 24-48 hours
|
TEWL will be evaluated by the device of Multi Probe Adapter 4.
|
infant 24-48 hours
|
Infant skin barrier function (Transepidermal Water Loss, TEWL)
Time Frame: infant 42 days old
|
TEWL will be evaluated by the device of Multi Probe Adapter 4.
|
infant 42 days old
|
Infant skin barrier function (Transepidermal Water Loss, TEWL)
Time Frame: infant 6 months old
|
TEWL will be evaluated by the device of Multi Probe Adapter 4.
|
infant 6 months old
|
Infant atopic dermatitis incidence by 1year old
Time Frame: from birth , to 12months old
|
Disease diagnosis according to the criteria of Williams
|
from birth , to 12months old
|
Infant skin barrier function (Stratum corneum hydration, SCH)
Time Frame: infant 24-48 hours
|
SCH will be evaluated by the device of Multi Probe Adapter 4.
|
infant 24-48 hours
|
Infant skin barrier function (Stratum corneum hydration, SCH)
Time Frame: infant 42 days old
|
SCH will be evaluated by the device of Multi Probe Adapter 4.
|
infant 42 days old
|
Infant skin barrier function (Stratum corneum hydration, SCH)
Time Frame: infant 6 months old
|
SCH will be evaluated by the device of Multi Probe Adapter 4.
|
infant 6 months old
|
Infant skin barrier function (skin surface pH)
Time Frame: infant 24-48 hours
|
Skin pH will be evaluated by the device of Multi Probe Adapter 4.
|
infant 24-48 hours
|
Infant skin barrier function (skin surface pH)
Time Frame: infant 42 days old
|
Skin pH will be evaluated by the device of Multi Probe Adapter 4.
|
infant 42 days old
|
Infant skin barrier function (skin surface pH)
Time Frame: infant 6 months old
|
Skin pH will be evaluated by the device of Multi Probe Adapter 4.
|
infant 6 months old
|
Infant skin barrier function (sebum content)
Time Frame: infant 24-48 hours
|
Sebum content will be evaluated by the device of Multi Probe Adapter 4.
|
infant 24-48 hours
|
Infant skin barrier function (sebum content)
Time Frame: infant 42 days old
|
Sebum content will be evaluated by the device of Multi Probe Adapter 4.
|
infant 42 days old
|
Infant skin barrier function (sebum content)
Time Frame: infant 6 months old
|
Sebum content will be evaluated by the device of Multi Probe Adapter 4.
|
infant 6 months old
|
Maternal serum Vitamin E level
Time Frame: 12-14 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
12-14 gestational weeks
|
Maternal serum Vitamin A level
Time Frame: 12-14 gestational weeks
|
Serum sample collected at different trimesters will be used for evaluation
|
12-14 gestational weeks
|
Child atopic dermatitis from 1 year old to 2 years old
Time Frame: from 1 year old to 2 years old
|
Disease diagnosis according to the criteria of Williams
|
from 1 year old to 2 years old
|
Child atopic dermatitis from 2 years old to 5 years old
Time Frame: from 2 years old to 5 years old
|
Disease diagnosis according to the criteria of Williams
|
from 2 years old to 5 years old
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Guoying Huang, MD,PhD, Children's Hospital of Fudan University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Wegienka G, Havstad S, Zoratti EM, Kim H, Ownby DR, Johnson CC. Association between vitamin D levels and allergy-related outcomes vary by race and other factors. J Allergy Clin Immunol. 2015 Nov;136(5):1309-14.e1-4. doi: 10.1016/j.jaci.2015.04.017. Epub 2015 Jun 12.
- Kiefte-de Jong JC, Timmermans S, Jaddoe VW, Hofman A, Tiemeier H, Steegers EA, de Jongste JC, Moll HA. High circulating folate and vitamin B-12 concentrations in women during pregnancy are associated with increased prevalence of atopic dermatitis in their offspring. J Nutr. 2012 Apr;142(4):731-8. doi: 10.3945/jn.111.154948. Epub 2012 Mar 7.
- Kelleher M, Dunn-Galvin A, Hourihane JO, Murray D, Campbell LE, McLean WHI, Irvine AD. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol. 2015 Apr;135(4):930-935.e1. doi: 10.1016/j.jaci.2014.12.013. Epub 2015 Jan 22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
October 31, 2017
Study Completion (Actual)
April 30, 2018
Study Registration Dates
First Submitted
August 31, 2016
First Submitted That Met QC Criteria
August 31, 2016
First Posted (Estimate)
September 5, 2016
Study Record Updates
Last Update Posted (Actual)
March 20, 2023
Last Update Submitted That Met QC Criteria
March 16, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AD2016-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atopic Dermatitis
-
Catalysis SLCompletedAtopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions | Atopic Dermatitis \(AD\)Serbia
-
Jacob Pontoppidan ThyssenThe Novo Nordic FoundationRecruitingAtopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis FlareDenmark
-
ShaperonNot yet recruitingAtopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis of Scalp
-
University of California, San FranciscoSanofi; Regeneron PharmaceuticalsRecruitingEczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related ConditionsUnited States
-
PfizerActive, not recruitingEczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, UnspecifiedUnited States, Canada, Czechia, Poland
-
AmgenCompletedDermatitis, Atopic DermatitisCanada, United States, Japan
-
Hadassah Medical OrganizationUnknownATOPIC DERMATITIS
-
SanofiCompletedAtopic Dermatitis | Dermatitis AtopicChina
-
SanofiCompletedDermatitis AtopicSaudi Arabia, Kuwait, United Arab Emirates
-
National Institute of Allergy and Infectious Diseases...Atopic Dermatitis Research NetworkCompletedAtopic Dermatitis (AD) | Non-atopic Healthy ControlsUnited States
Clinical Trials on maternal biological folate level
-
Brigham and Women's HospitalCharles H. Hood Foundation; Peter and Elizabeth C. Tower FoundationUnknown
-
Kem Hospital, Pune, IndiaUnknown
-
Fundacion para la Salud Materno InfantilTerminatedDelay Cord Clamping | Placental TrasfusionArgentina
-
Fundacion para la Salud Materno InfantilCompleted
-
MIS Implant Technologies, LtdThe University of Texas Health Science Center at San AntonioRecruiting
-
Shiphrah Biomedical Inc.Mitacs; University of TorontoRecruitingSleep Disorder | Sleep | Sleep Disturbance | Pregnancy Related | Sleep-Disordered BreathingCanada
-
University of Michigan Rogel Cancer CenterRush University Medical CenterCompletedPancreatic CancerUnited States
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Eskisehir Osmangazi UniversityUnknownEffects of Sleep Quality on Melatonin Levels and Inflammatory Response After Major Abdominal SurgerySleep DeprivationTurkey